Mizuho cuts Intel stock price target to $20, maintains neutral
Securities adjusted its outlook on Intel Corporation (NASDAQ:INTC), reducing the price target from $21.00 to $20.00 while sustaining a Neutral rating on the shares. This aligns with the broader ...
Mizuho Securities Remains a Buy on PPG Industries (PPG)
Mizuho Securities analyst John Roberts CFA maintained a Buy rating on PPG Industries (PPG – Research Report) yesterday and set a price target ...
Rakuten Scraps Plan to List Securities Unit on Tokyo Bourse
Rakuten Group Inc. said it no longer plans to list its securities arm on the Tokyo Stock Exchange, and will instead focus on ...
Japan's Rakuten Group scraps plan to list Rakuten Securities
Japan's Rakuten Group has decided not to seek a listing for Rakuten Securities on the Tokyo Stock Exchange, it said on ...
MarketWatch17d
Investors have 'a false sense of security' around 5% peak Treasury yields, says Mizuho
Yet "the bond market has not taken on board" the potential for 3% inflation in 2025, Steven Ricchiuto, chief economist at Mizuho Securities, wrote in a Monday client note. Even before December's ...
Seeking Alpha23d
Mizuho upgrades Vornado Realty, Cousins Properties, downgrades Kilroy
Mizuho Securities raised its recommendation on Vornado Realty Trust (NYSE:VNO) and Cousins Properties (NYSE:CUZ), and downgraded Kilroy Realty (NYSE:KRC), considering their geographic exposure and ...
Geneos Wealth Management Inc. Has $253,000 Holdings in The Clorox Company (NYSE:CLX)
Geneos Wealth Management Inc. lessened its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.3% during ...
The TRADE10d
KNG Securities taps Mizuho for new emerging markets fixed income specialist
Incoming individual brings 30 years’ experience in emerging markets debt to the role, having previously held positions at Mizuho International, VTB Capital, BNP Paribas, ING Nederland and CIBC World ...
Seeking Alpha6d
Qorvo in focus as Mizuho ups estimates on activist involvement
Qorvo (NASDAQ:QRVO) shares fell 0.5% in premarket trading on Friday, even as Mizuho Securities upped its earnings estimates on the involvement of activist investor Starboard Value. Mizuho analyst ...
Mizuho raises Sage Therapeutics target to $9 on Biogen bid
Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...